Renaissance Technologies LLC decreased its holdings in shares of Spok Holdings, Inc. (NASDAQ:SPOK - Free Report) by 2.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 975,650 shares of the Wireless communications provider's stock after selling 24,072 shares during the quarter. Renaissance Technologies LLC owned 4.81% of Spok worth $15,659,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently modified their holdings of SPOK. Geode Capital Management LLC boosted its holdings in Spok by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 514,427 shares of the Wireless communications provider's stock valued at $8,258,000 after acquiring an additional 6,591 shares during the period. State Street Corp boosted its stake in shares of Spok by 3.1% during the third quarter. State Street Corp now owns 415,876 shares of the Wireless communications provider's stock valued at $6,263,000 after purchasing an additional 12,467 shares during the period. JPMorgan Chase & Co. grew its holdings in shares of Spok by 7.6% in the fourth quarter. JPMorgan Chase & Co. now owns 213,575 shares of the Wireless communications provider's stock worth $3,428,000 after purchasing an additional 15,156 shares during the last quarter. Allspring Global Investments Holdings LLC increased its stake in Spok by 67.9% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 110,997 shares of the Wireless communications provider's stock worth $1,782,000 after buying an additional 44,896 shares during the period. Finally, Trexquant Investment LP lifted its holdings in Spok by 49.8% during the 4th quarter. Trexquant Investment LP now owns 106,467 shares of the Wireless communications provider's stock valued at $1,709,000 after buying an additional 35,401 shares in the last quarter. 50.81% of the stock is currently owned by hedge funds and other institutional investors.
Spok Stock Performance
Spok stock traded up $0.26 during midday trading on Friday, hitting $15.67. 103,012 shares of the company's stock were exchanged, compared to its average volume of 118,888. The company has a market cap of $319.97 million, a PE ratio of 21.47 and a beta of 0.40. The firm has a 50-day moving average of $16.15 and a two-hundred day moving average of $16.02. Spok Holdings, Inc. has a 12 month low of $13.24 and a 12 month high of $17.96.
Spok (NASDAQ:SPOK - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The Wireless communications provider reported $0.18 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.20 by ($0.02). The business had revenue of $33.89 million for the quarter, compared to the consensus estimate of $35.50 million. Spok had a net margin of 10.66% and a return on equity of 9.20%. As a group, equities analysts expect that Spok Holdings, Inc. will post 0.76 earnings per share for the current year.
Spok Cuts Dividend
The business also recently declared a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Friday, March 14th were given a $0.3125 dividend. This represents a $1.25 annualized dividend and a dividend yield of 7.98%. The ex-dividend date of this dividend was Friday, March 14th. Spok's payout ratio is 168.92%.
Analysts Set New Price Targets
SPOK has been the topic of a number of research analyst reports. B. Riley upgraded shares of Spok from a "neutral" rating to a "buy" rating and upped their target price for the stock from $15.00 to $20.00 in a research note on Thursday, February 27th. StockNews.com upgraded Spok from a "buy" rating to a "strong-buy" rating in a report on Tuesday, April 8th.
Get Our Latest Research Report on Spok
Spok Profile
(
Free Report)
Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager.
See Also

Before you consider Spok, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spok wasn't on the list.
While Spok currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.